Calif. heart device firm completes $48 million funding round

03/1/2013 | American City Business Journals

CardioKinetix has raised $23 million in the second tranche of its Series E funding round, bringing the total for that round to $48 million. The funding will enable the company to advance its efforts to bring its Parachute ventricular partitioning system designed for heart failure patients to the global market, President and CEO Maria Sainz said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT